Farms.com Home   News

Prop 12 Stirs Controversy in Missouri Hog Farming

Scott Hays, President of the National Pork Producers Council, revealed his decision not to adapt his Missouri hog farm to meet California's Proposition 12 animal welfare law.

The law mandates specific renovations for hog farms, but Hays expressed concerns over the profitability of these modifications. While some major pork producers like Hormel, Smithfield, and Tyson Foods have committed to complying with Prop 12, Hays cited his reluctance to risk his family's farm.

Proposition 12 sets strict standards, requiring California hog farmers to provide 24 square feet of floor space for each breeding sow. It also bans the sale of pork from farms in other states that don't meet this requirement. The NPPC has voiced its support for the EATS Act, which proposes enabling anyone to challenge state or local laws regulating agricultural product production in federal court. Critics argue that this act may undermine various state laws related to health, safety, and welfare.

Hays emphasized that the NPPC is actively working to find a solution to address Prop 12's challenges, appreciating the backing received from House Agriculture Committee Chair Glenn Thompson.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.